Haemonetics Acquires Attune Medical

March 5, 2024

Haemonetics Corporation has agreed to acquire privately-held Attune Medical, the maker of the FDA-cleared ensoETM esophageal cooling device, for $160 million upfront plus contingent consideration. The acquisition will expand Haemonetics' electrophysiology and temperature-management capabilities and is expected to close in Haemonetics' fiscal 2025 first quarter.

Buyers
Haemonetics Corporation
Targets
Attune Medical
Industry
Medical Devices
Location
Illinois, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.